Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced
the first presentation of positive safety and efficacy data from the
AUX-CC-867 MULTICORD (MULtiple Treatment Investigation of...
By Andy Batts:
BioSpecifics Technologies (NASDAQ:BSTC) recently announced positive, statistically significant results from a randomized, double-blind Phase 2a study of collagenase clostridium histolyticum or CCH (known as XIAFLEX in the in the US...
WASHINGTON (dpa-AFX) - Auxilium Pharmaceuticals, Inc. (AUXL), a specialty
biopharmaceutical company, announced positive results from a randomized,
double-blind Phase 2a trial of collagenase clostridium histolyticum or CCH for
Coca-Cola HBC AG (NYSE:CCH)
Q2 2014 Earnings Call
August 07, 2014 4:00 am ET
Basak Kotler - Investor Relations Director
Dimitris Lois - Chief Executive Officer, Executive Director and Chairman of Operating Committee
March 12, 2014
/PRNewswire/ -- The industry-impacting announcement by the Internal Revenue Service (IRS), now allowing electronic signatures on Form 8879, which authorizes electronic filing of tax returns, eliminates a...
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.
You may also be interested in articles related to Coca-Cola Hellenic Bottling Company (CCH):